Suzuki I am in the medical business for 40 years . Mitral valvular disease is a huge area but its a very complex valve. Edwards are spending big in this area as its the new frontier of expansion.Anteris are in bed with 4C but they had a problem or two but the concept of their valve was novel and exciting. All I was stating is that our best in class Adapt tissue will be a big winner for the future successful Mitral valve company. If WP sells the company in toto I would like that he takes the value of our adapt tissue for the mitral valve area into account and claim an extra $1b for shares holders.
Ann: Five TAVR Patients Successfully Implanted With DurAVR Valve, page-113
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.010(0.10%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.20 | $10.26 | $9.81 | $396.9K | 39.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1200 | $10.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 966 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |